Bioscience

New genomic test for coronary artery disease now available at Heart & Vascular Center of Arizona

November 23, 2009

By Flinn Foundation

[Source: PRNewswire] – The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain. Corus CAD is a new genomic test launched in select U.S. markets, and the Heart & Vascular Center of Arizona is among the first institutions in the country to offer this first-of-its-kind gene expression test to patients with possible cardiovascular disease.

For more information: New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona